Abstract:Aims. To identify whether phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase/extracellular-regulated protein kinases signalling pathways are implicated in the chemoresistance of gastric cancer and to explore the possible mechanisms.Methods. Gastric cancer cell lines SGC7901 and BGC823 were exposed to etoposide, Wortmannin + etoposide or PD98059 + etoposide. Cell cycle distribution and cell apoptosis were detected using flow cytometry and Hoechst 33258 staining. Cells viability was determined by a colourimetric assay utilising 3-(4,5-dimethyl thiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT). Akt activity was detected using non-radioactive immunoprecipitation-kinase assay. Western blotting was exploited to evaluate the level of phosphorylated ERK1/2 and expressions of c-Myc and p53 protein.Results. Etoposide suppressed the viability of SGC7901 and BGC823 cells in a time- and dose-dependent manner; PD98059 and Wortmannin were able to enhance the cytotoxicity of etoposide. The apoptotic levels of cells treated with Wortmannin+etoposide or PD98059+etoposide were significantly higher than those of cells treated with etoposide only. Phospho-ERK1/2, Akt activity and expression of c-Myc were significantly induced by etoposide in a time-dependent manner; moreover, there was a weak effect on the expression of p53 protein. Both Wortmannin and PD98059 elevated the level of p53 expression strikingly, however, only PD98059 suppressed the up-regulation trend of c-Myc expression induced by etoposide.Conclusion. Chemotherapy reagent activated phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase/extracellular-regulated protein kinases signalling pathways, which decreased the chemotherapy sensitivity of gastric cancer cell lines SGC7901 and BGC823 via suppressing the expression of p53 and enhancing the expression of c-Myc. This may be one of the molecular mechanisms of gastric cancer chemoresistance. (c) 2006 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.

Activity of PI3'K/Akt/FKHRL1 Signaling Pathway Induced by Doxorubicin Confer Chemoresistance in Gastric Cancer Cell

The Impact of Akt and Nuclear Factor Kb Pathway on Chemoresistance of Gastric Cancer Cell

[Impact of PI3K /akt /mdm2 Signaling Pathway on the Sensitivity of Gastric Cancer Cell Line SGC7901 to Doxorubicin].

Phosphoinositide 3-Kinase/akt Pathway Plays an Important Role in Chemoresistance of Gastric Cancer Cells Against Etoposide and Doxorubicin Induced Cell Death.

Co-Inhibition Of Glut-1 Expression And The Pi3k/Akt Signaling Pathway To Enhance The Radiosensitivity Of Laryngeal Carcinoma Xenografts In Vivo

Akt associates with nuclear factor kappaB and plays an important role in chemoresistance of gastric cancer cells.

Effect of Activation of Mcl-1 and PI3K Signal Transduction Pathway of Human Gastric Cancer Cells on the Sensitivity to Chemotherapy

Activation of Akt/c-Myc Signaling Pathway Suppressing the Apoptosis of Gastric Cancer Cells

Activation of Akt and ERK Signalling Pathways Induced by Etoposide Confer Chemoresistance in Gastric Cancer Cells.

Inhibition of the P38 Mapk Pathway Sensitizes Human Gastric Cells to Doxorubicin Treatment in Vitro and in Vivo

The AKT1/NF-kappaB/Notch1/PTEN Axis Has an Important Role in Chemoresistance of Gastric Cancer Cells

Phospho Akt Mediates Multidrug Resistance of Gastric Cancer Cells Through Regulation of P-gp, Bcl-2 and Bax.

Effect of PI3K/Akt Signaling Pathway on PRAS40Thr246 Phosphorylation in Gastric Cancer Cells

Upregulation of PIK3IP1 monitors the anti-cancer activity of PI3Kα inhibitors in gastric cancer cells

[Relationship Between CD133 and Chemoresistance in Human Gastric Cancer and Its Associated Mechanism].

Progress about Relationship with PI3K/Akt Signaling Pathway and tumor chemoresistance

Interaction Between CD133 and PI3K-p85 Promotes Chemoresistance in Gastric Cancer Cells

The AKT1|[sol]|NF-kappaB|[sol]|Notch1|[sol]|PTEN axis has an important role in chemoresistance of gastric cancer cells

Overexpression of AKT decreases the chemosensitivity of gastric cancer cells to cisplatin in vitro and in vivo.

Class I Phosphatidylinositol 3-Kinase Inhibitor LY294002 Activates Autophagy and Induces Apoptosis Through P53 Pathway in Gastric Cancer Cell Line SGC7901

DKK1 Promotes Epithelial–Mesenchymal Transition and Cisplatin Resistance in Gastric Cancer via Activation of the PI3K/AKT Pathway